Recombinant Anti-CD44 x Anti-CR3 Bispecific Antibody (IgG(L)-scFv) is formed by an IgG and two scFv moieties. The scFv fragments from an anti-CD44 antibody are fused to the C terminus of an anti-CR3 IgG light (L) chains, or vice versa. It is a type of appended IgGs, which is bispecific and tetravalent (2+2 antigen-binding valency). This BsAb can recruit macrophages to tumor cells. It is designed for the research of Glioblastoma; Squamous cancer therapy.
There are currently no customer reviews or questions for Recombinant Human Anti-CD44 x Human Anti-CR3 Bispecific Antibody (IgG(L)-scFv) (IGLFV-H295). Click the button below to contact us or submit your feedback about this product.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRYSERVICES
PRODUCTS
PLATFORMS